Studies of the mode of action of antitumor triazenes and triazines. 6. 1-Aryl-3-(hydroxymethyl)-3-methyltriazenes: synthesis, chemistry, and antitumor properties
- 1 March 1984
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 27 (3) , 357-363
- https://doi.org/10.1021/jm00369a020
Abstract
1-Aryl-3-(hydroxymethyl)-3-alkyltriazenes [ArN = NN(CH3)CH2OH] were synthesized by diazonium coupling to the carbinolamine (RNHCH2OH) generated in situ from the alkylamine and formaldehyde mixtures. The (hydroxymethyl)triazene structure was confirmed by IR, NMR and mass spectral analysis and also by the preparation of a crystalline benzoate derivative. The mass spectra of the (hydroxymethyl)triazenes suggest that they fragment by loss of formaldehyde to give the methyltriazene, which is also the product of hydrolysis in solution. The degradation of the (hydroxymethyl)triazenes in solution was followed by UV spectroscopy and by HPLC [high pressure liquid chromatography]analysis, and the half-lives were determined under a variety of conditions. The half-lives of the corresponding methyl- and (hydroxymethyl)triazenes are very similar. Both methyl- and(hydroxymethyl)triazenes decompose on silica plates during TLC analysis to give products consistent with known diazo-migration reactions. The (hydroxymethyl)triazenes have pronounced antitumor activity against the TLX5 tumor [mouse lymphoma] in vivo; in vivo-in vitro bioassay experiments suggest that the (hydroxymethyl)triazenes exert their in vivo antitumor activity via the degradation product, the alkyltriazene.This publication has 7 references indexed in Scilit:
- The formation and metabolism of N-hydroxymethyl compounds—IBiochemical Pharmacology, 1982
- The role of isocyanates in the toxicity of antitumour haloalkylnitrosoureasBiochemical Pharmacology, 1982
- Studies of the mode of action of antitumour triazenes and triazines—II. Investigation of the selective toxicity of 1-aryl-3,3-dimethyltriazenesBiochemical Pharmacology, 1981
- Urinary metabolite of 1-(2,4,6-trichlorophenyl)-3,3-dimethyltriazene with an intact diazoamino structureCancer Letters, 1979
- Antitumour activity, biomimetic oxidation and metabolism of heteroalicyclic triazenesBiochemical Pharmacology, 1979
- Chemical studies on carcinogenic nitrosamines. 1. Hydrolysis of .alpha.-acetoxynitrosaminesThe Journal of Organic Chemistry, 1978
- Tumour inhibitory triazenes: Structural requirements for an active metaboliteBiochemical Pharmacology, 1976